|
Kenneth Grabstein, Ph.D., Chief Scientific Officer Kenneth Grabstein joined Allozyne, Inc. as Chief Scientific Officer in October of 2005. Prior to joining the Allozyne team, Dr. Grabstein was at Immunex Inc, where he spent 12 years in R&D leading the discovery and characterization of cytokines and other protein immuno-modulators. He went on to co-found Corixa Inc and led a research team of 100 scientists engaged in the discovery and development of immuno-therapeutics. He has published over 100 articles in peer-reviewed scientific journals and is an inventor on over 20 issued patents. Dr. Grabstein has Affiliate Faculty positions at the University of Washington, and Roswell Park Cancer Institute. Kenneth Grabstein, Ph.D., received his Ph.D. in Immunology from U.C. Berkeley in 1982. | 